The efficacy and safety of wedge resection for peripheral stage IA lung adenocarcinoma: a real-world study based on a single center

被引:3
|
作者
Bian, Dongliang [1 ]
Xiong, Yicheng [1 ]
Jin, Kaiqi [1 ]
Zhu, Yuming [1 ]
Yu, Huansha [2 ]
Dai, Jie [1 ]
Jiang, Gening [1 ]
机构
[1] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Thorac Surg, Shanghai, Peoples R China
[2] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Anim Expt Ctr, Shanghai, Peoples R China
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
Lung adenocarcinoma stage IA; wedge resection; recurrence; SECTION COMPUTED-TOMOGRAPHY; LIMITED RESECTION; SUBLOBAR RESECTION; SURVIVAL OUTCOMES; CANCER; LOBECTOMY; IMPACT; CLASSIFICATION;
D O I
10.21037/jtd-22-1010
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: The effectiveness of segmentectomy for stage IA lung adenocarcinoma (IA-LUAD) has been well-documented. However, the efficacy and safety of wedge resection for peripheral IA-LUAD remains controversial. This study evaluated the feasibility of wedge resection in patients with peripheral IA-LUAD. Methods: Patients with peripheral IA- LUAD who underwent wedge resection by video- assisted thoracoscopic surgery (VATS) at Shanghai Pulmonary Hospital were reviewed. Cox proportional hazards modeling was performed to identify predictors of recurrence. Receiver operating characteristic (ROC) curve analysis was used to calculate the optimal cutoffs of identified predictors. Results: A total of 186 patients (female/male, 115/ 71; mean age, 59.9 years) were included. Mean maximum dimension of consolidation component (MCD) was 5.6 mm, consolidation-to-tumor ratio (CTR) was 37%, and mean computed tomography value of tumor (CTVt) was -285.4 HU. With a median follow-up of 67 months (interquartile range, 52-72 months), the 5-year recurrence rate was 4.84%. Ten patients occurred recurrence postoperatively. No recurrence was observed adjacent to the surgical margin. Increasing MCD, CTR, and CTVt were associated with a higher risk of recurrence, with corresponding hazard ratios (HRs) of 1.212 [95% confidence interval (CI): 1.120-1.311], 1.054 (95% CI: 1.018-1.092), and 1.012 (95% CI: 1.004-1.019) with optimal cutoffs for predicting recurrence of 10 mm, 60%, and -220 HU, respectively. When a tumor had characteristics under these respective cutoffs, no recurrence was observed. Conclusions: Wedge resection can be considered to be a safe and efficacious management strategy for patients with peripheral IA-LUAD, especially for MCD less than 10 mm, CTR less than 60% and CTVt less than -220 HU.
引用
收藏
页码:54 / 64
页数:11
相关论文
共 50 条
  • [21] Differential efficacy of segmentectomy and wedge resection in sublobar resection compared to lobectomy for solid-dominant stage IA lung cancer: a systematic review and meta-analysis
    Lin, Huahang
    Peng, Zhiyu
    Zhou, Ke
    Liang, Linchuan
    Cao, Jie
    Huang, Zhaokang
    Chen, Lonqi
    Mei, Jiandong
    INTERNATIONAL JOURNAL OF SURGERY, 2024, 110 (02) : 1159 - 1171
  • [22] Robotic Versus Thoracoscopic Sub-lobar Resection for Octogenarians with Clinical Stage IA Non-small Cell Lung Cancer: A Propensity Score-Matched Real-World Study
    Pan, Hanbo
    Zou, Ningyuan
    Tian, Yu
    Shen, Yaofeng
    Chen, Hang
    Zhu, Hongda
    Zhang, Jiaqi
    Jin, Weiqiu
    Gu, Zenan
    Ning, Junwei
    Jiang, Long
    Huang, Jia
    Luo, Qingquan
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (03) : 1658 - 1659
  • [23] Efficacy and Safety of Anlotinib in Advanced Non-Small Cell Lung Cancer: A Real-World Study
    Zhang, Kun
    Ma, Xiya
    Gao, Hongjun
    Wang, Hong
    Qin, Haifeng
    Yang, Shaoxing
    Liu, Xiaoqing
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 3409 - 3417
  • [24] Real-World Study on Implementation of Genomic Tests for Advanced Lung Adenocarcinoma in Brazil
    Dienstmann, Rodrigo
    da Silva, Leonard M.
    do Rego, Fernanda Orpinelli Ramos
    Rodrigues, Amanda Muniz
    Koyama, Fernanda Christtanini
    Galindo, Layla Testa
    Fernandes, Carolina de Bustamante
    de Souza, Bruno Batista
    Paes, Rafael Duarte
    Montella, Tatiane
    de Marchi, Pedro
    Araujo, Breno Jeha
    Ferrari, Bruno Lemos
    Mathias, Clarissa
    Pereira, Emilio
    Zalis, Mariano Gustavo
    Leslin, Chesley
    Ferreira, Carlos Gil
    JCO GLOBAL ONCOLOGY, 2024, 10
  • [25] Clinicopathological features and survival outcomes for gastric adenocarcinoma: Real-world single-center data
    Charles, L.
    Elangovan, Archana
    Nisha, Yadav
    Jafa, Esha
    Kate, Vikram
    Selvarajan, Sandhiya
    Kayal, Smita
    Ganesh, Rajesh Nachiappa
    Dubashi, Biswajit
    Penumadu, Prasanth
    Ganesan, Prasanth
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2024, 43 (06) : 1209 - 1219
  • [26] Postoperative tegafur-uracil for stage I lung adenocarcinoma: first real-world data with an exploratory subgroup analysis
    Miyata, Ryo
    Hamaji, Masatsugu
    Nakakura, Akiyoshi
    Morita, Satoshi
    Shimazu, Yumeta
    Ishikawa, Masashi
    Kayawake, Hidenao
    Menju, Toshi
    Sakaguchi, Yasuto
    Sonobe, Makoto
    Takahashi, Mamoru
    Aoyama, Akihiro
    Sumitomo, Ryota
    Huang, Cheng-Long
    Kono, Tomoya
    Miyahara, Ryo
    Matsumoto, Akira
    Katakura, Hiromichi
    Fukada, Takahisa
    Sakai, Hiroaki
    Kobayashi, Masashi
    Okumura, Norihito
    Date, Naoki
    Fujinaga, Takuji
    Miyamoto, Ei
    Nakagawa, Tatsuo
    Date, Hiroshi
    SURGERY TODAY, 2023, 53 (01) : 135 - 144
  • [27] Estimating the cure proportion of stage IA lung adenocarcinoma: a population-based study
    Huang, Zhixin
    Chen, Dinghang
    Hong, Zhinuan
    Kang, Mingqiang
    BMC PULMONARY MEDICINE, 2023, 23 (01)
  • [28] Real-world treatment patterns and clinical outcomes in EGFR-mutant locally advanced lung adenocarcinoma: A multi-center cohort study
    Bi, Nan
    Xu, Kunpeng
    Ge, Hong
    Chen, Ming
    Mingyan, E.
    Zhang, Li
    Cao, Jianzhong
    Zhang, Xu
    Ding, Xiao
    Xia, Bing
    Zhao, Lujun
    Han, Lijie
    Li, Jiancheng
    Hu, Chen
    Wang, Luhua
    JOURNAL OF THE NATIONAL CANCER CENTER, 2023, 3 (01): : 65 - 71
  • [29] Real-world effectiveness and safety of bosentan in Japanese patients with systemic sclerosis: A single-center retrospective study
    Ishikawa, Mai
    Endo, Yukie
    Yamazaki, Sahori
    Sekiguchi, Akiko
    Uchiyama, Akihiko
    Motegi, Sei-ichiro
    JOURNAL OF DERMATOLOGY, 2023, 50 (06) : 828 - 832
  • [30] Real-world Safety and Effectiveness of Edoxaban in Patients with Venous Thromboembolism with or without Preceding Parenteral Anticoagulants: A Single-center Retrospective Study
    Ueno, Yuki
    Ikeda, Satoshi
    Motokawa, Tetsufumi
    Honda, Tomohiro
    Kurobe, Masaya
    Akashi, Ryohei
    Yonekura, Tsuyoshi
    Yoshimuta, Tsuyoshi
    Eguchi, Masamichi
    Kawano, Hiroaki
    Maemura, Koji
    INTERNAL MEDICINE, 2023, 63 (13) : 1845 - 1853